Microarrays test in heart transplant care
Part of Heart & circulation clinical trials.
This study checks how special lab tests on heart tissue samples can help guide diagnosis and treatment for people with a heart transplant. You may be eligible if you already need a heart tissue biopsy for a clinical reason and can provide consent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be scheduled for a heart tissue biopsy for a medical reason
- You must be able to give informed consent (agree to join)
- You cannot be pregnant at the time of joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying whether a blood test that measures small molecules called microRNAs can help doctors personalize the medicines used to prevent rejection after a heart transplant. If you qualify, you would help researchers learn how to better match immunosuppression to each patient's needs.
This study looks at how special lab tests from tiny tissue samples (microarrays) could help guide diagnosis and treatment in people who receive a liver transplant. It may help doctors better understand what’s going on and choose care more accurately.
This trial uses precise, personalized approaches to manage heart transplant recipients. It involves taking a small heart muscle sample (a biopsy) to monitor for rejection or routine checks.
This study looks at using a special lab test (microarrays) on tissue taken during a lung transplant biopsy. It aims to learn how the test may help doctors better diagnose and guide care after transplant.
This study tests whether a small biopsy taken from a donor heart before transplant can predict how well the heart will work after surgery. The goal is to improve transplant success for recipients.
This study looks at changes in blood and heart biopsy samples to help detect or understand transplant rejection. You may benefit by contributing to research that could improve future rejection screening and care.
Hear when a new Cardiac Transplant Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.